ISET 2026
Three-Year Outcomes from the PERFORMANCE II Trial: A Prospective Multicenter Study of the Neuroguard IEP® 3-in-1 Carotid Stent System
03/24/2026
In this video, interventional cardiologist William A. Gray, MD, FACC, MSCAI, from Lankenau Heart Group in Wynnewood, Pennsylvania, highlights the key findings from his presentation at ISET 2026, “Three-Year Outcomes from the PERFORMANCE II Trial: A Prospective Multicenter Study of the Neuroguard IEP® 3-in-1 Carotid Stent System”. Dr. Gray reviews the study’s design, clinical endpoints, and 3-year results, offering insight into the safety, efficacy, and sustained performance of this novel integrated embolic protection carotid stent system in the treatment of carotid artery stenosis.


